The mean Aβ load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 5, 1997, Pages 531-540

  Bartoo, Grace T ^a   Nochlin, David ^a   Chang, Dooyong ^a   Kim, Yongmin ^a   Sumi, S Mark ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

A load; Correlation; Familial Alzheimer disease; Hippocampus; Image analysis; Immunocytochemistry

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 14; CLINICAL ARTICLE; COGNITION; DEMENTIA; DISEASE DURATION; DISEASE SEVERITY; FAMILIAL DISEASE; GENETIC LINKAGE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIORITY JOURNAL;

EID: 0030735176     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199705000-00009     Document Type: Article

References (36)

1. Goate AM, Haynes AR, Owen MJ, Farrall M, James LA, Lai LYC, et al. Predisposing locus for Alzheimer's disease on chromosome 21. Lancet 1989;1:352:355
2. Goate AM, Chartier-Harlin CM, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-6
3. Schellenberg GD, Deeb SS, Boehneke ML, Bryant EM, Martin GM, Lampe TH, Bird TD. Association of an apolipoprotein CII allele with familial dementia of the Alzheimer type. J Neurogenet 1987;4:97-108
4. Pericak-Vance MA, Bebout JL, Gaskell, Jr. PC, Yamaoka LH, Hung W-Y, Alberts MJ, et al. Linkage studies in familial Alzheimer disease: Evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-50
5. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258: 668-71
6. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KAB, Weber JL, et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995;269:970-73
7. Strittmatter WJ, Saunders AM, Schmechel DE, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci 1993;90: 1977-81
8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science 1993;261:921-23
9. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
10. Hyman BT, Tanzi RE, Marzloff K, Barbour R, Schenk D. Kunitz protease inhibitor-containing amyloid β protein precursor immunoreactivity in Alzheimer's disease. J Neuropathol Exp Neurol 1992;51(1):76-83
11. Hsu SM, Fanger H. Use of avidin biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-80
12. Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987;57:230-36
13. Bartoo GT. Quantitative neuropathological measures in Alzheimer's disease [doctoral thesis]. University of Washington. 1995
14. Miller AKH, Alston RL, Corsellis JAN. The practical application of image-analyzing systems to neuropathology: Principles and possible scope. In: Smith WT, Cavanagh JB, eds., Recent advances in neuropathology. Num. 1. Edinburgh: Churchill Livingston, 1979: 113-28
15. Kirkwood BR. Essentials of medical statistics. Oxford: Blackwell Scientific Publications, 1988
16. Fisher LD, van Belle G. Biostatistics. A methodology for the health sciences. New York: John Wiley & Sons, 1993
17. Schmechel DE, Saunders AM, Strittmatter WJ, Grain BJ, Hulette CM, Joo SH, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:9649-53
18. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992;42:1681-88
19. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann Neurol 1990;27(5):457-64
20. Hyman BT, Marzloff K, Arriagada PV. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 1993;52(6):594-600
21. Neary D, Snowden JS, Mann DMA, Bowen DM, Sims NR, Northen B, et al. Alzheimer's disease: A correlative study. J Neurol Neurosurg Psychiatry 1986;49:229-37
22. Nochlin D, Van Belle G, Bird TD, Sumi SM. Comparison of the neuropathologic changes in familial and sporadic Alzheimer's disease. Alzheim Dis Assoc Disord 1993;7:212-22
23. Samuel W, Terry RD, DeTeresa R, Butters N, Masliah E. Clinical correlation of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol 1994;51:772-78
24. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80
25. Wilcock GK, Esiri MM. Plaques, tangles, and dementia. A quantitative study. J Neurol Sci 1982;56:343-56
26. Cairns NJ, Chadwick A, Luthert PJ, Lantos PL. β-amyloid protein load is relatively uniform throughout neocortex and hippocampus in elderly Alzheimer's disease patients. Neurosci Lett 1991;129: 115-18
27. Gentleman SM, Allsop D, Bruton CJ, Jagoe R, Polak JM, Roberts GW. Quantitative differences in the deposition of βA4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's disease. Neurosci Lett 1992;136:27-30
28. Gentleman SM, Williams B, Royston MC, et al. Quantification of βA4 protein deposition in the medial temporal lobe: A comparison of Alzheimer's disease and senile dementia of the Lewy body type. Neurosci Lett 1992;142:9-12
29. McKenzie JE, Gentleman SM, Royston MC, Edwards RJ, Roberts GW. Quantification of plaque types in sulci and gyri of the medial frontal lobe in patients with Alzheimer's disease. Neurosci Lett 1992;142:9-12
30. Arriagada PV, Growden JH, Hedley-Whyte ET Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-39
31. Ball MJ, Fisman M, Hachinski V, Blume W, Fox A, Kral VA, et al. A new definition of Alzheimer's disease: Hippocampal dementia. Lancet 1985;1(8419):14-16
32. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
33. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques, and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991;12:295-312
34. Mann DMA, Marcyniuk B, Yates PO, Neary D, Snowden JS. The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropath Appl Neurobiol 1988;14:177-95
35. Bennett DA, Cochran EJ, Saper CB, Leverenz JB, Gilley DW, Wilson RS. Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease. Neurobiol Aging 1993;14:589-96
36. Cairns NJ, Chadwick A, Lantos PL, Levy R, Rosser MN. βA4 protein deposition in familial Alzheimer's disease with the mutation in codon 717 of the βA4 amyloid precursor protein gene and sporadic Alzheimer's disease. Neurosci Let 1992;149:137-40